Hearing Loss Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 45 and 64 years old and have severe to profound hearing loss in both ears that developed after you learned to speak, and even with hearing aids you can only understand up to 70% of spoken words in a quiet setting (confirm with trial site)
- Alternatively, you may be eligible as a "control" participant if you have normal hearing and are matched to a case participant in terms of age, sex, and education level
Who may not be able to join:
- You have a disability that would prevent you from completing the tests required by the trial
- You have a current or past history of neurological or psychiatric conditions, including having had meningitis
- You are currently taking medication that affects mood, behaviour, or mental function (such as antidepressants, antipsychotics, or similar drugs)
- You are considered a vulnerable person (confirm with trial site for the specific definition used)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Isabelle Dr MOSNIER, MD, Assistance Publique - Hôpitaux de Paris
Phone: 142162612
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of Mini Mental State Examination to access cognitive impairment in patients with severe to profound hearing loss compare to subjects with normal hearing; Evaluation of Trail making tests (TMT) A et B to evaluate executive functions in patients with severe to profound hearing loss compare to subjects with normal hearing; Evaluation of "Fluences verbales sémantique et phonémique" to evaluate linguistic skills in patients with severe to profound hearing loss compare to subjects with normal hearing; Evaluation of 16-item Free and Cue Selective Recall Test (RLRI/16) to evaluate episodic...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.